Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986
Peer-ReviewedPubMedResearch ArticleTherapeuticInternational journal of radiation oncology, biology, physics · 2026

Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience.

Côté N, Sun L, Nagar H, Brennan V, Chan CY, Maggia G (+5 more)

Abstract

PurposeTo develop and evaluate 2 simulation-free (SF) stereotactic body radiation therapy (SBRT) workflows for prostate cancer on magnetic resonance (MR)-Linac: one using a diagnostic MR reference scan and another using a preapproved template scan.Methods and materialsPopulation-based relative electron density (RED) values were derived from 100 prostate SBRT patients on the Elekta Unity MR-Linac and validated on a separate cohort of 10 patients for dosimetric equivalence. Two SF approaches were evaluated in another independent cohort of 10 patients using reference plans derived from: (1) a diagnostic MR scan (5 retrospective, 5 prospective), and (2) a digitally created pelvic phantom scan using population-based RED (all retrospective). The performance of artificial intelligence-generated contours was investigated during adaptive treatments using surface Dice (sDSC) with 1 mm tolerance and added path length. All adaptive plans, from both SF and the clinically delivered workflow, were compared in terms of dose metrics and monitor unit usage. A focused failure modes and effects analysis identified and mitigated diagnostic MR SF-specific risks by calculating the risk priority number (RPN).ResultsPopulation-based RED assignments resulted in mean dose differences under 1%. Artificial intelligence contours showed strong agreement with physician-approved contours, with sDSC and added path length of 0.96/26.2cm,0.98/17.2cm,0.99/0.4cm, and 0.99/0.01cm for bladder, rectum, penile bulb, and bone, respectively. Across both SF workflows, adaptive plans were clinically comparable to the standard workflow, with mean dose differences from -1.7% to 4.6% and mean monitor unit differences remaining under 2%. Failure modes and effects analysis identified 3 high-risk failure modes: mislabeling diagnostic MR scans (RPN=39), case tracking lapses (RPN=29), and incorrect RED assignment (RPN=22), all mitigated through workflow refinements and training. The diagnostic MR SF workflow has been clinically implemented, treating 22 patients without failures.ConclusionsBoth SF workflows eliminated the need for simulation, streamlining adaptive prostate SBRT without compromising plan quality. The template-based workflow further improved patient access by removing imaging prerequisites.

Related in the same topics